Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster
NACompletedINTERVENTIONAL
Enrollment
66
Participants
Timeline
Start Date
January 31, 1997
Conditions
Herpes ZosterImmunologic Deficiency Syndromes
Interventions
DRUG
Valacyclovir
Trial Locations (1)
77058
Center for Clinical Studies, Houston
All Listed Sponsors
collaborator
University of Texas
OTHER
lead
National Center for Research Resources (NCRR)
NIH
NCT00006131 - Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster | Biotech Hunter | Biotech Hunter